-
- Testing Information
- Testing Specialties
- Suite of Services
- Research
- Education
- About ARUP
- ARUP Connect
ARUP Laboratories
ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests. More about ARUP
In Focus
ARUP and Seattle Children's Hospital Collaborate on Utilization Management via Seattle Children's PLUGS Program
PLUGS helps pediatric hospital laboratories and practitioners decrease costs and errors associated with unnecessary laboratory testing. ARUP is the first Gold sponsor of this innovative utilization management program.
New Test Update: Cerdelga (Eliglustat) Monitoring Tests, Plasma
Cerdelga (eliglustat) is an FDA-approved medication for certain adults with Gaucher disease type 1.
Please visit our Cerdelga information page to learn more about test choice and interpretation.
ARUP's Dr. Lyon Invited to Attend the Precision Medicine Initiative
Dr. Elaine Lyon and Dr. Timothy O'Leary in front of the White House on Jan 30, 2015; the Office of Science and Technology Policy issued this prestigious invitation to Dr. Lyon to hear President Obama speak regarding investments to improve health and treat disease.
President Obama on the Precision Medicine Initiative (video) Presidential remarks on Precision Medicine
FDA Oversight of LDTs Will Create Negative Effects Across Healthcare
ARUP is a vocal opponent of the FDA's proposed oversight of laboratory-developed tests (LDTs).
Dr. Ashwood testifies during the FDA Public Workshop. Dr. Lyon testifies during the FDA Public Workshop. World-renowned medical centers speak out against FDA regulation of LDTs.
ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform
NGS.Web contains gene and variant data from unique partnerships and industry-leading databases, including PierianDx and the GeneInsight VariantWire network. This innovative platform will enhance sample tracking, data analysis, and reporting of genetic and oncological sample testing.
